Aspirin for Preventing the Recurrence of Venous Thromboembolism
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: About 20% of patients with unprovoked venous thromboembolism have a recurrence within 2 years after the withdrawal of oral anticoagulant therapy. Extending anticoagulation prevents recurrences but is associated with increased bleeding. The benefit of aspirin for the prevention of recurrent venous thromboembolism is unknown. METHODS: In this multicenter, investigator-initiated, double-blind study, patients with first-ever unprovoked venous thromboembolism who had completed 6 to 18 months of oral anticoagulant treatment were randomly assigned to aspirin, 100 mg daily, or placebo for 2 years, with the option of extending the study treatment. The primary efficacy outcome was recurrence of venous thromboembolism, and major bleeding was the primary safety outcome. RESULTS: Venous thromboembolism recurred in 28 of the 205 patients who received aspirin and in 43 of the 197 patients who received placebo (6.6% vs. 11.2% per year; hazard ratio, 0.58; 95% confidence interval [CI], 0.36 to 0.93) (median study period, 24.6 months). During a median treatment period of 23.9 months, 23 patients taking aspirin and 39 taking placebo had a recurrence (5.9% vs. 11.0% per year; hazard ratio, 0.55; 95% CI, 0.33 to 0.92). One patient in each treatment group had a major bleeding episode. Adverse events were similar in the two groups. CONCLUSIONS: Aspirin reduced the risk of recurrence when given to patients with unprovoked venous thromboembolism who had discontinued anticoagulant treatment, with no apparent increase in the risk of major bleeding. (Funded by the University of Perugia and others; WARFASA ClinicalTrials.gov number, NCT00222677.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The WARFASA 309 and ASPIRE 318 trials compared aspirin, 100 mg daily, with placebo for secondary prevention of recurrent VTE for patients with an initial unprovoked event, and the pooled results of the 2 trials showed a decrease in recurrent VTE, as well as major vascular events, without an increased risk for clinically relevant bleeding. 309,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [309]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Consequently, several studies have investigated the role of aspirin for the secondary prevention of VTE. 309,314,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [309]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007903 · Cited by 3,237
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
Prandoni, P., Lensing, A. W. A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A. M., Polistena, P., Bernardi, E., & Prins, M. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00001 · Cited by 2,109
Self-citationAntithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Self-citationAntithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Self-citation(2000) · The Lancet · doi:10.1016/s0140-6736(00)02110-3 · Cited by 1,076
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
del Conde, I., Shrimpton, C. N., Thiagarajan, P., & López, J. A. (2005) · Blood · doi:10.1182/blood-2004-03-1095 · Cited by 1,029
Schulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Lärfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322501 · Cited by 932
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
Ridker, P. M., Goldhaber, S. Z., Danielson, E., Rosenberg, Y., Eby, C. S., Deitcher, S. R., Cushman, M., Moll, S., Kessler, C. M., Elliott, C. G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035029 · Cited by 808
Linkins, L.-A., Choi, P. T., & Douketis, J. D. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00007 · Cited by 764
Research works printed but not linked: 2
- Schulman S, 2011, J Thromb Haemost, 9, 731
- Schulman S, 2011, J Thromb Haemost, 9, 22
Cited by
Items 401–500 of 630
Plotnik, A. N., Haber, Z. M., & Kee, S. T. (2024) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-024-03898-4 · Cited by 4
Thrombocytosis and Essential Thrombocythemia
Barbui, T., Finazzi, G., & Tefferi, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00047-3 · Cited by 4
Stroke and Myocardial Infarction with Hormonal Contraception
Siegel, A. J. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1208930 · Cited by 4
Aspirin for preventing venous thromboembolism.
Brighton, T., Eikelboom, J. W., & Simes, J. (2013) · PubMed · doi:10.1056/nejmc1215492 · Cited by 3
Top practice-changing articles over the last two years
Kaatz, S., & Gage, B. F. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-0896-x · Cited by 3
von Treuheim, T. D. P., Ruff, G. L., Shanaa, J., Schwarzkopf, R. M., & Aggarwal, V. K. (2025) · The Journal of Arthroplasty · doi:10.1016/j.arth.2025.09.020 · Cited by 3
Pharmacological management of pulmonary embolism
Gouin, B., Robert‐Ebadi, H., Righini, M., & Blondon, M. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1268122 · Cited by 3
Strategien zur Antikoagulation bei Patienten mit tiefer Beinvenenthrombose und Lungenarterienembolie
Radke, P. W., & Möckel, M. (2017) · Herz · doi:10.1007/s00059-017-4655-1 · Cited by 3
Acute inferior vena cava thromboembolism in pregnancy
Bilyalova, G., Iskalieva, S., Baibusunova, A., & Boshanova, A. (2024) · BMJ Case Reports · doi:10.1136/bcr-2023-258667 · Cited by 3
Management of Acute Pulmonary Embolism: A Review
Bhave, A. A., Dumra, H. S., & Bansal, S. (2024) · Journal of the Association of Physicians of India · doi:10.59556/japi.72.0737 · Cited by 3
Anticoagulation Therapy for Venous Thromboembolism
Anjum, P., Utz, A. E., Kimbrell, M., & Akbashev, M. Y. (2025) · Medical Clinics of North America · doi:10.1016/j.mcna.2025.02.017 · Cited by 3
Nouveaux anticoagulants oraux dans le traitement curatif de la maladie thromboembolique veineuse
Bertoletti, L., Lega, J., Moulin, N., Buchmuller, A., Mismetti, P., & Decousus, H. (2013) · La Presse Médicale · doi:10.1016/j.lpm.2013.06.001 · Cited by 4
Aspirine et prévention de la maladie veineuse thromboembolique : la suite d’une belle histoire
Ferrières, C., Conard, J., & Blacher, J. (2013) · Journal des Maladies Vasculaires · doi:10.1016/j.jmv.2012.12.001 · Cited by 3
Anticoagulation after venous thromboembolism: Deciding on the optimal duration
Eichinger, S. (2013) · Hämostaseologie · doi:10.5482/hamo-13-03-0015 · Cited by 3
Self-citationExtended oral anticoagulation after incident venous thromboembolism – a paradigm shift?
Albertsen, I. E., Piazza, G., Søgaard, M., Nielsen, P. B., & Larsen, T. B. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2020.1755260 · Cited by 3
Baby, N., Kunnathuparambil, S., Varghese, P., & Kuriakose, A. M. (2020) · Neurology India · doi:10.4103/0028-3886.288990 · Cited by 3
Place actuelle des anticoagulants oraux directs dans la maladie thromboembolique veineuse
Roffé, A., Guédon, A. F., & Lallmahomed, E. (2021) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2021.06.005 · Cited by 4
Sciascia, S., Radin, M., & Schreiber, K. I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00045-x · Cited by 3
Investigación de la trombofilia venosa. Presente y futuro
Vilalta, N., & Souto, J. C. (2014) · Angiología · doi:10.1016/j.angio.2014.03.001 · Cited by 4
Duerschmied, D., Nitschmann, S., & Bode, C. (2013) · Der Internist · doi:10.1007/s00108-013-3377-6 · Cited by 4
Epperla, N., Peterson, E. L., & Foy, P. C. (2015) · BMC Hematology · doi:10.1186/s12878-015-0025-5 · Cited by 3
Treatment and Long-Term Management of Venous Thromboembolism
AlBadri, A., & Spyropoulos, A. C. (2014) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2014.06.011 · Cited by 3
Moeinipour, A., Zarifian, A., Andalibi, M. S. S., Shamloo, A. S., Ahmadabadi, A., Amouzeshi, A., & Hoseinikhah, H. (2015) · The Heart Surgery Forum · doi:10.1532/hsf.1348 · Cited by 3
An Algorithmic Approach to Management of Venous Thromboembolism
Dhakal, P., Gundabolu, K., & Bhatt, V. R. (2016) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029616652727 · Cited by 4
Anticoagulation Beyond 3 to 6 Months: What Does the Data Tell Us?
Carman, T. L. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.04.002 · Cited by 3
Treatment of deep vein thrombosis
Lauw, M. N., & Buller, H. R. (2014) · doi:10.2217/fmeb2013.13.98 · Cited by 5
The secondary prevention of venous thromboembolism: Towards an individual therapeutic strategy
Elmi, G., Pizzini, A. M., & Silingardi, M. (2018) · Vascular · doi:10.1177/1708538118776896 · Cited by 3
Self-citationMengxin, Z., Sun, R., & 陈跃鑫 (2018) · Chinese Medical Sciences Journal · doi:10.24920/21805 · Cited by 3
Pulmonary artery thrombosis: strategy of anticoagulation
Porembskaya, О. Y., Кравчук, В. Н., Lobastov, K. V., Kuzmina-Krutetskaya, S. R., Laberko, L. A., Chesnokov, M. S., Velikanova, K. E., & Saiganov, S. A. (2021) · Pirogov Russian Journal of Surgery · doi:10.17116/hirurgia202111176 · Cited by 4
Venous and Arterial Thrombosis Is There a Link?
Prandoni, P. (2015) · Advances in experimental medicine and biology · doi:10.1007/13780_2015_13 · Cited by 3
Self-citationKumbhani, D. J., Armbruster, A. L., Cheng, R. K., Chrispin, J., Fischer, U., Holbrook, A. M., Joglar, J., & Sevestre, M.-A. (2026) · JACC · doi:10.1016/j.jacc.2026.05.033 · Cited by 2
Effect of Aspirin Use on clinical Outcome among Critically Ill Patients with COVID- 19
Ali, R. M. M., Tharwat, A. I., & Labib, H. A. (2022) · Egyptian Journal of Anaesthesia · doi:10.1080/11101849.2022.2139104 · Cited by 2
Practical guide to management after an acute pulmonary embolism
Alikhan, R., Howard, L., Johnson, M., Sweeney, S., Kiely, D. G., & Pepke‐Żaba, J. (2025) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2024-003028 · Cited by 2
Kaneda, K., Yamashita, Y., Morimoto, T., Chatani, R., Nishimoto, Y., Ikeda, N., Kobayashi, Y., Ikeda, S., Kim, K., Inoko, M., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0464 · Cited by 2
Sinsakolwat, P., Trongtrakul, K., Tajarernmuang, P., Inmutto, N., Niprapan, P., Norasetthada, L., Tantiworawit, A., Rattarittamrong, E., Rattanathammethee, T., Hantrakool, S., et al. (2025) · Thrombosis Journal · doi:10.1186/s12959-025-00793-x · Cited by 2
Clinical roundtable monograph: Paroxysmal nocturnal hemoglobinuria: a case-based discussion.
Szer, J., Hill, A., & Weitz, I. C. (2012) · PubMed · Cited by 2
Catheter ablation of atrial fibrillation to reduce stroke risk
Schmidt, B., Bordignon, S., Fürnkranz, A., & Chun, K. R. J. (2013) · Herz · doi:10.1007/s00059-013-3776-4 · Cited by 2
Jiménez, D., & Uresandi, F. (2014) · Angiología · doi:10.1016/j.angio.2014.02.003 · Cited by 3
Platelets as Regulators of Thrombosis and Inflammation
Duerschmied, D., & Maßberg, S. (2017) · Cardiac and vascular biology · doi:10.1007/978-3-319-66224-4_4 · Cited by 3
ANTICOAGULANT THERAPY OF VENOUS THROMBOEMBOLIC COMPLICATIONS: PROBLEMS AND PERSPECTIVES
Vorobieva, N. M., & Панченко, Е. П. (2015) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2015-2-7-17 · Cited by 3
Komarov, A. L. (2019) · Kardiologiia · doi:10.18087/cardio.2019.2.10232 · Cited by 2
Treatment of Acute Venous Thromboembolism
Nair, S. N., Garza, N., George, M., & Kaatz, S. (2020) · Medical Clinics of North America · doi:10.1016/j.mcna.2020.03.004 · Cited by 3
Anticoagulants and antiaggregants in the COVID-19 era
Erlikh, A. D. (2021) · Aterotromboz = Atherothrombosis · doi:10.21518/2307-1109-2021-11-1-58-66 · Cited by 2
Statins during Anticoagulation for Emergency Life-Threatening Venous Thromboembolism: A Review
Siniscalchi, C., Imbalzano, E., Meschi, T., Ticinesi, A., Prati, B., Basaglia, M., Camporese, G., Perrella, A., Viorica, A., Eletto, E., et al. (2024) · Medicina · doi:10.3390/medicina60081240 · Cited by 4
Platelets in Deep Venous Thrombosis and Pulmonary Embolism
Pabinger, I., Riedl, J., & Panzer, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-47462-5_69 · Cited by 2
Venous thromboembolism: Diagnosis, treatment and the prevention of long-term complications
Barnes, G. D., Froehlich, J. B., Kanthi, Y. M., & Wakefield, T. W. (2014) · Reviews in vascular medicine · doi:10.1016/j.rvm.2014.07.005 · Cited by 2
Okabe, T., Araki, H., Yakushiji, T., Ebara, S., Yamashita, K., Yamamoto, M. H., Saito, S., Hoshimoto, K., Amemiya, K., Isomura, N., et al. (2014) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2014.05.011 · Cited by 2
Toth, P. P. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.912833 · Cited by 3
Vardi, M., Piazza, G., Pencina, M. J., Burke, D., Lei, L., Goldhaber, S. Z., & Cutlip, D. E. (2014) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029613517166 · Cited by 3
Mookadam, M., Shamoun, F., Ramakrishna, H., Obeid, H., Rife, R., & Mookadam, F. (2015) · Annals of Cardiac Anaesthesia · doi:10.4103/0971-9784.166461 · Cited by 2
Mahan, C. E., Fields, L. E., Mills, R. M., Stephenson, J. J., Fu, A.-C., Fisher, M. D., & Spyropoulos, A. C. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-02-0108 · Cited by 2
Agents antiplaquettaires : les recommandations ANSM/HAS et leur emploi aux urgences
Monsuez, J. J., Arnould, M. A., & Artigou, J. Y. (2012) · Journal Européen des Urgences et de Réanimation · doi:10.1016/j.jeurea.2012.10.003 · Cited by 2
Managing Extended Oral Anticoagulation After Unprovoked Venous Thromboembolism
Joseph, L., & Bartholomew, J. R. (2016) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248416652236 · Cited by 2
Morris, T. A., & Fedullo, P. F. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00057-9 · Cited by 4
Potential risk factors for recurrent pulmonary embolism in hospitalized patients
Wang, L., Wang, W., Shu, T., Feng, P., Xiang, R., & Huang, W. C. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-36 · Cited by 2
Krasiński, Z., Urbanek, T., Undas, A., Rupa‐Matysek, J., Araszkiewicz, A., Derwich, K., Klotzka, A., Antoniewicz, A. A., Krasińska, B., Piwkowski, C., et al. (2021) · Acta Angiologica · doi:10.5603/aa.2021.0006 · Cited by 2
McKenzie, A. J., Doyle, B. J., & Aman, Z. M. (2022) · Cardiovascular Engineering and Technology · doi:10.1007/s13239-022-00618-2 · Cited by 2
Andrade, A. A., & Gage, B. F. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3378-3 · Cited by 2
Comerota, A. J. (2018) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2018.03.011 · Cited by 2
Acetylsalicylsäure und venöse Thrombosen
Schrör, K. (2015) · Der Internist · doi:10.1007/s00108-014-3622-7 · Cited by 2
Zielgerichtete Antiangiogenese mit Bevacizumab und vaskuläre Ereignisse
Loew, A., & Riess, H. B. (2013) · Der Onkologe · doi:10.1007/s00761-012-2360-5 · Cited by 2
Antiplatelet Therapy in Cardiovascular Disease
Schmaier, A. A., & Bhatt, D. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-97873-4_18 · Cited by 2
Becattini, C., & Vedovati, M. C. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.08.2201 · Cited by 2
Self-citationOptimal duration of anticoagulant therapy in patients with venous thromboembolism
Palareti, G. (2018) · Italian Journal of Medicine · doi:10.4081/item.2018.1077 · Cited by 1
Liang, J., Alavinia, M., & Kumbhare, D. A. (2018) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001046 · Cited by 1
[Antithrombotic therapy after iliac vein stenting].
Zhong, W., Lou, Y., Qiu, C., Li, D., & Zhang, H. (2020) · PubMed · doi:10.3785/j.issn.1008-9292.2020.02.15 · Cited by 2
Hashimoto, H., Imai, S., Kiyomi, A., & Sugiura, M. (2022) · Thrombosis Update · doi:10.1016/j.tru.2022.100113 · Cited by 1
Venous thromboembolism prophylaxis in total shoulder arthroplasty: a matched cohort analysis
Katakam, A., Joshi, T., Soussou, T. S., Sirch, F., Ogilvie, D., Jones, T., Yedikian, T., & Erickson, J. (2026) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s00402-026-06291-7 · Cited by 1
Chen, J., Liu, S., Shen, Y., Xiong, H., Chen, C., Xiao, B., Wang, Y., Lu, J., Yu, W., Xu, D., et al. (2025) · Thrombosis and Haemostasis · doi:10.1055/a-2706-9879 · Cited by 1
Drug delivery systems for the treatment of venous thrombosis
Li, Y., Gong, Y., Mo, L., Zhu, T., Dai, Y., Hu, X., Zhu, Y., Zhao, Y., & He, J. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111983 · Cited by 1
Suresh, M. G., Mohamed, S., Geetha, H. S., Sekar, A., Prabhu, S., Sargent, J., Abraham, G. M., Hatwal, J., Batta, A., & Mohan, B. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i11.110178 · Cited by 1
Managing patients with a history of arterial disease and new venous thromboembolism
Deng, E., & Passam, F. H. (2025) · Hematology · doi:10.1182/hematology.2025000683 · Cited by 1
Wei, X., Chen, W., Zhang, J., & Mao, J. (2025) · Thrombosis Journal · doi:10.1186/s12959-025-00803-y · Cited by 1
LYRA, G. O. T., Katsuyama, E. S., Pincelli, M. P., de Almeida, V. P., Prado, M. L. D. L., Pereira, S. B., Tinoco, J. A., Nunes, M. A. P., & Fernandes, C. J. C. D. S. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.12.012 · Cited by 2
Durée optimale du traitement anticoagulant au décours d’une embolie pulmonaire
Tromeur, C., & Couturaud, F. (2015) · La Presse Médicale · doi:10.1016/j.lpm.2015.07.005 · Cited by 1
Taniguchi, T., Kato, M., Ueda, S., Yokomatsu, T., Mizoguchi, T., Miki, S., & Yoshida, A. (2015) · Journal of Cardiac Surgery · doi:10.1111/jocs.12512 · Cited by 1
Blickstein, D., Eliakim‐Raz, N., & Gafter‐Gvili, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011088 · Cited by 1
Tromboembolia pulmonar: revisión sistemática y algoritmo diagnóstico-terapéutico
Gorordo-Delsol, L. A., Zamora-Gómez, S. E., Hernández-López, G. D., García-Román, M. T. A., Jiménez-Ruiz, A., & Tercero-Guevara, B. I. (2015) · Revista del Hospital Juárez de México · Cited by 1
Trombosis venosa y arterial: semejanzas e implicaciones clínicas
Páramo, J. A. (2013) · Medicina Clínica · doi:10.1016/j.medcli.2013.07.021 · Cited by 2
Platelet recruitment to venous stent thrombi
McBane, R. D., Karnicki, K., & Wysokiński, W. E. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-0924-x · Cited by 1
Pernod, G. (2013) · Journal des Maladies Vasculaires · doi:10.1016/j.jmv.2012.12.003 · Cited by 1
Jiménez, D., Kopecna, D., de Miguel‐Díez, J., & Sueiro, A. (2014) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(14)70882-0 · Cited by 2
Current treatment strategies for management of antiphospholipid syndrome
Reggia, R., Andréoli, L., Tincani, A., & Shoenfeld, Y. (2014) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2014.881734 · Cited by 4
Watson, H. G. (2012) · Evidence-Based Nursing · doi:10.1136/eb-2012-100896 · Cited by 1
Lungenembolie auf der Intensivstation
Dürschmied, D., Heinz, J., Siepe, M., & Bode, C. (2015) · Intensivmedizin up2date · doi:10.1055/s-0034-1391389 · Cited by 1
Venous pulmonary thromboembolism and atherothrombosis: need for a new approach.
Aursulesei, V. O., & Roca, I. C. (2014) · The Medical-Surgical Journal · Cited by 1
The Optimal Duration of Anticoagulation in Patients with Unprovoked Venous Thromboembolism
Prandoni, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_108 · Cited by 1
Self-citationExploring unmet needs in venous and arterial thromboembolism with rivaroxaban
Cappato, R., & Welsh, R. C. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-06-0484 · Cited by 1
The management of venous thromboembolism: A practical tool for the front-line clinician
Bungard, T. J., & Semchuk, W. (2017) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163517691062 · Cited by 1
NEW PROSPECTS IN THE SECONDARY PREVENTION OF VENOUS THROMBOSIS
Laguta, P. S. (2016) · Aterotromboz = Atherothrombosis · doi:10.21518/2307-1109-2016-1-5-15 · Cited by 1
Quel traitement anticoagulant au décours d’une embolie pulmonaire
Mao, R. L., Tromeur, C., & Couturaud, F. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.06.015 · Cited by 1
Anticoagulation for Proximal Deep Vein Thrombosis
Lee, A. I., & Lee, E. (2017) · Springer eBooks · doi:10.1007/978-3-319-65226-9_23 · Cited by 1
CLINICAL DISCUSSION OF A PATIENT WITH RECURRENT VENOUS THROMBOEMBOLIC COMPLICATIONS
Komarov, A. L. (2017) · Aterotromboz = Atherothrombosis · doi:10.21518/2307-1109-2017-2-79-94 · Cited by 1
Lawall, H. (2018) · Gefässchirurgie · doi:10.1007/s00772-018-0402-z · Cited by 1
The Management of Venous Thromboembolic Disease
Obi, A. T., & Wakefield, T. W. (2018) · Advances in Surgery · doi:10.1016/j.yasu.2018.03.005 · Cited by 1
Zawilska, K. (2018) · Acta Haematologica Polonica · doi:10.2478/ahp-2018-0009 · Cited by 1
Die verlängerte Sekundärprophylaxe nach venöser Thrombose
Bauersachs, R. M., & Schimmelpfennig, J. (2018) · Phlebologie · doi:10.12687/phleb2448-6-2018 · Cited by 1
Updates in venous thromboembolism management: evidence published in 2017
Bartlett, M. A., Bierle, D. M., Saadiq, R. A., Mauck, K. F., & Daniels, P. R. (2018) · Hospital Practice · doi:10.1080/21548331.2018.1486676 · Cited by 1
Long term use of anticoagulant therapy for patients with pulmonary embolism
Becattini, C., & Cimini, L. A. (2020) · Expert Review of Hematology · doi:10.1080/17474086.2020.1770589 · Cited by 1
Self-citationManagement of the Acute Thrombus-Bearing IVC Filter
Lessne, M. L., & Holly, B. P. (2020) · Springer eBooks · doi:10.1007/978-3-030-45150-9_13 · Cited by 2
Metadata
- Authors
- Becattini, C., Agnelli, G., Schenone, A., Eichinger, S., Bucherini, E., Silingardi, M., Bianchi, M., Moia, M., Ageno, W., Vandelli, M. R., Grandone, E., & Prandoni, P.
- Affiliations
- University of Perugia (IT)
- Ente Ospedaliero Ospedali Galliera (IT)
- Medical University of Vienna (AT)
- Ospedale per gli Infermi (IT)
- Santa Maria Nuova Hospital (IT)
- Ospedale Valduce (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- University of Insubria (IT)
- Casa Sollievo della Sofferenza (IT)
- University of Padua (IT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-05-24
- Volume
- 366
- Issue
- 21
- Pages
- 1959-1967
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1975990989
- Cited by
- 620
- References
- 37
- Citations by year
- 2026: 10 · 2025: 27 · 2024: 19 · 2023: 11 · 2022: 23 · 2021: 39 · 2020: 40 · 2019: 34 · 2018: 45 · 2017: 53 · 2016: 52 · 2015: 75 · 2014: 69 · 2013: 90 · 2012: 33
- FWCI
- 57.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Iris (University of Trento) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Funders
- Bristol-Myers Squibb
- Pfizer
- GlaxoSmithKline
- Sanofi
- Bayer HealthCare
- Università degli Studi di Perugia
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Keywords
- aspirin, venous thromboembolism, recurrence prevention, unprovoked venous thromboembolism, major bleeding, secondary prevention, anticoagulation
- MeSH terms
- Aged, Anticoagulants, Aspirin, Double-Blind Method, Female, Follow-Up Studies, Hemorrhage, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Pulmonary Embolism, Vitamin K, Venous Thrombosis, Venous Thromboembolism, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.